Item 5. Market for Registrant’s Common Equity
Item 5. Market for Registrant’s
Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities
Market Information
Our Units, Class A ordinary shares and warrants
are traded on the Nasdaq under the symbols “DNMXU”, “DNMX” and “DNMXW”, respectively. Our Units commenced
public trading on October 31, 2025, and our Class A ordinary shares and warrants began separate trading on November 19, 2025. There is
no trading market for our Class B ordinary shares.
Holders
As of March 18, 2026, there was one holder of
record of our Units, one holder of record of our separately traded Class A ordinary shares, one holder of record of our separately traded
public warrants, and one holder of record of our Class B ordinary shares.
Dividends
We have not paid any cash dividends on our ordinary
shares to date and do not intend to pay cash dividends prior to the completion of our initial business combination. The payment of cash
dividends in the future will be dependent upon our revenues and earnings, if any, capital requirements and general financial condition
subsequent to completion of our initial business combination. The payment of any cash dividends subsequent to our initial business combination
will be within the discretion of our board of directors at such time. Further, if we incur any indebtedness in connection with our business
combination, our ability to declare dividends may be limited by restrictive covenants we may agree to in connection therewith.
Securities Authorized for Issuance Under Equity
Compensation Plans
None
Recent Sales of Unregistered Securities; Use
of Proceeds from Registered Offerings
Unregistered Sales
On June 24, 2025, we issued an aggregate of 5,750,000
Class B ordinary shares, par value $0.0001 per share to our sponsor, for an aggregate purchase price of $25,000. On September 16, 2025,
we effected a 1 to 1.1666666087 share split of the founder shares, which resulted in a total of 6,708,333 founder shares held by our sponsor
. Such securities were issued pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
Simultaneous with the closing of the initial public
offering and the issuance and sale of the Units, the Company consummated the private placement of 6,275,000 private placement warrants
at a price of $1.00 per private placement warrant, generating total gross proceeds of $6,275,000. The sale of the private placement warrants
was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act.
Use of Proceeds
The registration statement on Form S-1 (File No.
333-289517) for our initial public offering was declared effective by the SEC on October 29, 2025. On October 31, 2025, the Company consummated
the initial public offering of 20,125,000, including 2,625,000 Units as a result of the underwriters’ full exercise of their overallotment
option, at an offering price of $10.00 per Unit. The gross proceeds from the initial public offering were $201,250,000 in the aggregate.
A total of $201,250,000 of the net proceeds of
the initial public offering and private placement, were placed in a trust account maintained by the Odyssey Transfer and Trust Company
acting as trustee. Transaction costs amounted to approximately $12,690,485, consisting of $4,025,000 of cash underwriting fees, $8,050,000
of deferred underwriting fees and approximately $615,485 of other offering costs. There has been no material change in the planned use
of proceeds from such use as described in the Company’s registration statement on Form S-1 (File No. 333-289517).
Item 6. [Reserved]
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.